SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients
Authors:
Open Access
- 22 December 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 1033770
Abstract
Background: Although SARS-CoV-2 vaccines have proven effective in eliciting a protective immune response in healthy individuals, their ability to induce a durable immune response in immunocompromised individuals remains poorly understood. Primary antibody deficiency (PAD) syndromes are among the most common primary immunodeficiency disorders in adults and are characterized by hypogammaglobulinemia and impaired ability to mount robust antibody responses following infection or vaccination.Methods: Here, we present an analysis of both the B and T cell response in a prospective cohort of 30 individuals with PAD up to 150 days following initial COVID-19 vaccination and 150 days post mRNA booster vaccination.Results: After the primary vaccination series, many of the individuals with PAD syndromes mounted SARS-CoV-2 specific memory B and CD4+ T cell responses that overall were comparable to healthy individuals. Nonetheless, individuals with PAD syndromes had reduced IgG1+ and CD11c+ memory B cell responses following the primary vaccination series, with the defect in IgG1 class-switching rescued following mRNA booster doses. Boosting also elicited an increase in the SARS-CoV-2-specific B and T cell response and the development of Omicron-specific memory B cells in COVID-19-naïve PAD patients. Individuals that lacked detectable B cell responses following primary vaccination did not benefit from booster vaccination.Conclusion: Together, these data indicate that SARS-CoV-2 vaccines elicit memory B and T cells in most PAD patients and highlights the importance of booster vaccination in immunodeficient individuals.Keywords
All Related Versions
This publication has 65 references indexed in Scilit:
- Genetic Diagnosis Using Whole Exome Sequencing in Common Variable ImmunodeficiencyFrontiers in Immunology, 2016
- Genes associated with common variable immunodeficiency: one diagnosis to rule them all?Journal of Medical Genetics, 2016
- Primary antibody deficienciesNature Reviews Immunology, 2013
- BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathwayNature Communications, 2012
- Toll-like receptor 7 (TLR7)–driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunityBlood, 2011
- Immunoglobulin treatment in primary antibody deficiencyInternational Journal of Antimicrobial Agents, 2011
- Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccinationVaccine, 2011
- Atypical Memory B Cells Are Greatly Expanded in Individuals Living in a Malaria-Endemic AreaThe Journal of Immunology, 2009
- Common Variable Immunodeficiency Patient Classification Based on Impaired B Cell Memory Differentiation Correlates with Clinical AspectsJournal of Clinical Immunology, 2003
- Severe deficiency of switched memory B cells (CD27+IgM−IgD−) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous diseaseBlood, 2002